Cambridge Cognition appoints Mick Holton as an Executive Director

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that Michael (Mick) Holton will join the Board as an Executive Director with immediate effect.

Mick has been serving the Company as Chief Financial Officer (CFO) since 19 January this year during a period of handover from the Company’s former CFO, Nick Walters, who stepped down from the Board at the Company’s AGM held on 27 May 2021.

Mick has had an extensive career in finance.  Prior to joining the Company, he was Interim CFO at AIM quoted Biome Technologies plc and prior to that, CFO at Infinis, a renewable energy generator.  Mick has also held senior finance roles at Alliance Boots (now part of Walgreens Boots Alliance) and Kidde plc (now part of United Technologies Corporation).

Mick qualified as a Chartered Accountant with Deloitte in 1998.

The following information regarding the appointment of Michael Damien Holton (aged 48) is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

Former directorships and/or partnerships (within the last five years)

Company NamePositionDate of AppointmentDate of Cessation
Infinis Energy Group Holdings LtdCFO/Director13 Jan 201701 Mar 2019
Aveley Methane LtdDirector08 Dec 201601 Mar 2019
Bidston Methane LtdDirector08 Dec 201601 Mar 2019
Blackborough End Energy LtdDirector08 Dec 201601 Mar 2019
Costessey Energy LtdDirector08 Dec 201601 Mar 2019
Gengas LimitedDirector08 Dec 201601 Mar 2019
Infinis (Re-Gen) LtdDirector08 Dec 201601 Mar 2019
Infinis Alternative Energies LtdDirector08 Dec 201601 Mar 2019
Infinis China (Investments) LtdDirector08 Dec 201601 Mar 2019
Infinis Energy Services LtdDirector08 Dec 201601 Mar 2019
Infinis Hydro Holdings LtdDirector08 Dec 201601 Mar 2019
Infinis Hydro LtdDirector08 Dec 201601 Mar 2019
Infinis LtdDirector08 Dec 201601 Mar 2019
Mayton Wood Energy LtdDirector08 Dec 201601 Mar 2019
Novera Acquisitions LtdDirector11 May 201701 Mar 2019
Novera Energy LtdDirector11 May 201701 Mar 2019
Novera Energy Generation No. 1 LtdDirector08 Dec 201601 Mar 2019
Novera Energy Generation No. 2 LtdDirector08 Dec 201601 Mar 2019
Novera Energy Generation No. 3 LtdDirector08 Dec 201601 Mar 2019
Novera Energy (Holdings 1) LtdDirector11 May 201701 Mar 2019
Novera Energy (Holdings 2) LtdDirector08 Dec 201601 Mar 2019
Novera Energy Operating Services LtdDirector08 Dec 201601 Mar 2019
Novera Energy Services UK LtdDirector08 Dec 201601 Mar 2019
Novera Ventures LtdDirector11 May 201701 Mar 2019
Renewable Power Generation LtdDirector08 Dec 201601 Mar 2019
Scottish Biofuel LtdDirector08 Dec 201601 Mar 2019
Scottish Biopower LtdDirector08 Dec 201601 Mar 2019
Infinis Energy Management LtdDirector13 Jan 201701 Mar 2019
Barbican Holdco LtdDirector11 Apr 201801 Mar 2019
Alkane Energy CM Holdings LtdDirector11 Apr 201801 Mar 2019
Alkane Energy CM LtdDirector11 Apr 201801 Mar 2019
Alkane Energy LtdDirector11 Apr 201801 Mar 2019
Alkane Biogas LtdDirector11 Apr 201801 Mar 2019
Regent Park Energy LtdDirector11 Apr 201801 Mar 2019
MW Renewables LtdDirector11 Apr 201801 Mar 2019
Barbican Bidco LtdDirector11 Apr 201801 Mar 2019
Rhymney Power LtdDirector11 Apr 201801 Mar 2019
Alkane Energy UK LtdDirector11 Apr 201801 Mar 2019
Seven Star Natural Gas LtdDirector11 Apr 201801 Mar 2019
Alkane Services LtdDirector11 Apr 201801 Mar 2019
Leven Power LtdDirector11 Apr 201801 Mar 2019

There are no further statements to be made under Schedule 2 (g) of the AIM Rules.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition investor webinar on 3 May 2023

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, will be announcing the Company’s preliminary financial results for the year ended 31 December 2022 on Wednesday 3 May 2023 and

Cambridge Cognition Holdings

Cambridge Cognition Holdings confirm date for year end results

Cambridge Cognition Holdings Plc (LON: COG), which develops and markets digital solutions to assess brain health, has confirmed that it will announce the Company’s preliminary financial results for the year ended 31 December 2022, on Wednesday 3

Cambridge Cognition Holdings

Cambridge Cognition wins two contracts worth over £2.1 million

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won two sizeable contracts, together worth over £2.1 million, to provide the Company’s CANTAB® cognitive assessments

Cambridge Cognition Holdings

Cambridge Cognition 25% growth in revenues to £12.6 million

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a trading update for the year ended 31 December 2022. Unaudited highlights for the year ended 31 December 2022 ·         Revenue

Cambridge Cognition Holdings

Cambridge Cognition acquires Winterlight Labs Inc

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced the acquisition of Winterlight Labs Inc, a leader in monitoring cognitive impairment through free-speech analysis.  The total consideration for the

Cambridge Cognition Holdings

Cambridge Cognition plc investor live webinar today

The interim results for the six months ended 30 June 2022 were released earlier today on 20 September 2022. The Company will conduct a live presentation and Q&A session for investors later today at 5:30 pm BST.

Cambridge Cognition Holdings

Cambridge Cognition growth in revenue of 31%

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced its unaudited interim results for the six months ended 30 June 2022. The Company followed its strong performance in 2021 with

Cambridge Cognition Holdings

Cambridge Cognition partnering with the University of Oxford

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it will be collaborating with the University of Oxford by providing cognitive assessments for the Impact of Semaglutide

Cambridge Cognition Holdings

Cambridge Cognition signs two PTSD trial agreements

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced two agreements in a new therapeutic area for the Company, post-traumatic stress disorder.  Most recently, a research agreement was

Cambridge Cognition Holdings

Cambridge Cognition directors buy shares in company

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, announced today that it was informed on the 21st July 2022 of the following purchases of the Company’s ordinary shares by Directors and PDMRs